Markos Negash
Impact in
- Infectious Diseases top 10%
- Tuberculosis Research and Epidemiology
- Infection Control in Healthcare
- COVID-19 Clinical Research Studies
-
- Hepatitis B Virus Studies
- Mycobacterium research and diagnosis
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Tuberculosis Research and Epidemiology 3
- HIV/AIDS Research and Interventions 1
- Infection Control in Healthcare 1
-
- Adipokines, Inflammation, and Metabolic Diseases 2
- Fungal Infections and Studies 1
- Co-authors
- Birhanu Ayelign (4 shared papers)Demeke Geremew (6 shared papers)Tewodros Shibabaw (2 shared papers)Debasu Damtie (3 shared papers)Biruk Bayleyegn (1 shared paper)Aklilu Endalamaw (2 shared papers)Belay Tessema (2 shared papers)Teklay Gebrecherkos (1 shared paper)
In The Last Decade
Markos Negash
23 papers receiving 437 citations
Peers
Comparison fields: 5 of 74
- Infectious Diseases 184
- Epidemiology 134
- Hepatology 24
- Microbiology 14
- Applied Microbiology and Biotechnology 4
Countries citing papers authored by Markos Negash
This map shows the geographic impact of Markos Negash's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markos Negash with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markos Negash more than expected).
Fields of papers citing papers by Markos Negash
This network shows the impact of papers produced by Markos Negash. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markos Negash. The network helps show where Markos Negash may publish in the future.
Co-authors
The 25 scholars most cited alongside Markos Negash, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 120 | |
| 2 | 2021 | 43 | |
| 3 | 2019 | 33 | |
| 4 | 2020 | 32 | |
| 5 | 2019 | 31 | |
| 6 | 2020 | 30 | |
| 7 | 2021 | 25 | |
| 8 | 2018 | 14 | |
| 9 | 2022 | 14 | |
| 10 | 2018 | 12 | |
| 11 | 2022 | 11 | |
| 12 | 2022 | 11 | |
| 13 | 2022 | 10 | |
| 14 | 2020 | 10 | |
| 15 | 2021 | 10 | |
| 16 | 2018 | 9 | |
| 17 | 2019 | 7 | |
| 18 | 2020 | 6 | |
| 19 | 2020 | 5 | |
| 20 | 2017 | 5 |
About Markos Negash
Markos Negash is a scholar working on Infectious Diseases, Epidemiology, Immunology, Microbiology and Surgery, having authored 25 papers that have together received 449 indexed citations. Recurring topics across this work include Tuberculosis Research and Epidemiology (3 papers), Adipokines, Inflammation, and Metabolic Diseases (2 papers), Helicobacter pylori-related gastroenterology studies (2 papers), Fungal Infections and Studies (1 paper), HIV/AIDS Research and Interventions (1 paper), Gastrointestinal disorders and treatments (1 paper), Infection Control in Healthcare (1 paper) and Infectious Diseases and Tuberculosis (1 paper). The work is most often cited by research in Infectious Diseases (184 citations), Epidemiology (134 citations), Hepatology (24 citations), Microbiology (14 citations) and Applied Microbiology and Biotechnology (4 citations). Markos Negash has collaborated with scholars based in Ethiopia, Belgium and Australia. Frequent co-authors include Birhanu Ayelign, Demeke Geremew, Tewodros Shibabaw, Debasu Damtie, Biruk Bayleyegn, Aklilu Endalamaw, Belay Tessema, Teklay Gebrecherkos, Habtamu Wondifraw Baynes and Setegn Eshetie. Their work appears in journals such as BMC Infectious Diseases, Journal of Immunology Research, Infection and Drug Resistance, BMC Endocrine Disorders and BMC Clinical Pathology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.